Giddy CEO Brett Jacobson says: “You’ve got roughly 50 million men suffering from ED in the US alone and yet 70% to 80% of these men don’t utilise an ED treatment, not because they’re not willing to spend the money and not because they’re not willing to put in the effort, but because they have tried everything in the past and nothing has worked for them.” How do other ED devices work?ĮD rings work best for patients who can achieve an erection but cannot maintain it. Now registered as a Class II medical device with the US Food and Drug Administration (FDA), the inventors hope Eddie can help more people with ED experience enjoyable sex lives. Medtech start-up Giddy has now developed a novel ED device called Eddie that aims to rethink the way physical interventions can help manage erectile dysfunction. This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments.ĪPAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry.
0 Comments
Leave a Reply. |